TrialClinical and vaccine immunology : CVI2006

Type-specific antibodies to pneumococcal capsular polysaccharide acquired either naturally or after vaccination with Prevenar in children with underlying chronic or recurrent lung diseases.

David Navarro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.